Client News
Carbios licensing documentation ready for worldwide industrial and commercial deployment of its PET biorecycling technology
Destiny Pharma: notice of full year results and investor presentation
ONWARD publishes first annual ESG summary
Mainz Biomed reports positive results from feasibility study evaluating its portfolio of novel mRNA biomarkers for early detection of advanced colorectal adenomas
Théa Open Innovation and Galimedix announce strategic partnership to develop and commercialize GAL-101, a Phase 2/3-ready small molecule, to treat ophthalmic indications with high unmet medical need
Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry
ONWARD: convocation of the 2023 annual general meeting of shareholders and proposed resolutions
ONWARD reports 2022 full year financial and operating results
Apogenix’ partner CANbridge announces 67 % five-year overall survival rate compared to 8.2 % in institutional database with asunercept plus standard of care in newly diagnosed glioblastoma multiforme patients